Department of Otolaryngology - Head & Neck Surgery, Derby Royal Infirmary, Derby DE1 2QY, UK.
Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Dec;129(6):302-7. doi: 10.1016/j.anorl.2011.10.012. Epub 2012 Aug 24.
To evaluate the clinical outcomes of total laryngectomy (TL), complications and factors affecting survival.
Retrospective review of hospital electronic database for head and neck squamous cell carcinoma (SCCa).
Large district general hospital in England, United Kingdom.
Patients who had TL between January 1994 and January 2008.
5-year disease specific survival (DSS) and disease-free survival (DFS).
Seventy-one patients were reviewed, of whom 38 (54%) had laryngeal SCCa and 33 (46%) hypopharyngeal SCCa. The overall mean survival period following TL was 42.4 months. The 5-year DSS and DFS was better for laryngeal SCCa compared to hypopharyngeal SCCa, although not statistically significant (P=0.090, P=0.54 respectively). Patients treated for laryngeal SCCa had a mean survival period of 47.5 months compared to 36.5 months for hypopharyngeal disease. Those who had laryngeal recurrence after primary radiotherapy (RT) demonstrated statistically better survival probability than those who had hypopharyngeal recurrence (P=0.011). Patients without cervical lymphadenopathy had statistically better survival (P=0.049). The most common early complication was related to the cardiorespiratory system. One fatal complication of erosion of the brachiocephalic artery due to the laryngectomy tube was noted. The most common late complication was neopharyngeal stenosis. The commonest cause of death was due to locoregional recurrence, followed by medical co-morbidities. Patients referred to specialised head and neck clinic had a better survival probability than those referred to a general ENT clinic (P=0.37). While there is increasing tendency towards laryngeal conservation, total laryngectomy remains a robust treatment option in selected patients.
评估全喉切除术(TL)的临床疗效、并发症及影响生存的因素。
回顾性分析英国某大型地区综合医院头颈鳞癌(SCCa)患者的电子病历数据库。
英国某大型地区综合医院。
1994 年 1 月至 2008 年 1 月期间行 TL 的患者。
5 年疾病特异性生存率(DSS)和无病生存率(DFS)。
共纳入 71 例患者,其中 38 例(54%)为喉 SCCa,33 例(46%)为下咽 SCCa。TL 后患者的中位生存时间为 42.4 个月。喉 SCCa 患者的 5 年 DSS 和 DFS 好于下咽 SCCa,但差异无统计学意义(P=0.090,P=0.54)。原发放疗(RT)后发生喉局部复发的患者生存概率显著高于下咽局部复发的患者(P=0.011)。无颈部淋巴结转移的患者生存概率显著高于有淋巴结转移的患者(P=0.049)。最常见的早期并发症与心肺系统有关。1 例因喉切除管侵蚀锁骨下动脉而导致的致命性并发症。最常见的晚期并发症是咽狭窄。最常见的死亡原因是局部区域复发,其次是合并症。转至头颈专科就诊的患者生存概率高于转至普通耳鼻喉科就诊的患者(P=0.37)。尽管保留喉的趋势日益增加,但全喉切除术仍是某些患者的有效治疗选择。